Latest News

PREVENT: AHA’s new risk calculator incorporates CKM health


 

FROM CIRCULATION

Knowledge gaps

The scientific statement lists several knowledge gaps and areas for more research. These include:

  • Incorporating “net benefit” to identify the expected benefit of treatment recommendations based on an individual’s level of risk.
  • Collecting more data from people of diverse race and ethnic backgrounds to better represent the increasing diversity in the United States. The number of Hispanic and Asian people included in the PREVENT datasets is lower than national estimates in the general U.S. population, so risk estimations in these populations may be less precise.
  • Expanding the collection, reporting, and standardization of social determinants of health data, such as individual information rather than neighborhood information.
  • Expanding risk assessment and prevention to earlier in life (childhood and/or adolescence) and in key life periods, such as during the peripartum period, since adverse pregnancy outcomes are associated with increased CVD risk.
  • Investigating whether predicting adverse kidney outcomes, particularly among people with and without type 2 diabetes, may further optimize cardiovascular risk prediction.

The scientific statement was prepared by the volunteer writing group on behalf of the AHA. Dr. Khan reports no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Statin misinformation on social media flagged by AI
MDedge Endocrinology
Troponin to ID diabetes patients with silent heart disease?
MDedge Endocrinology
High Lp(a) tied to higher coronary plaque volume, progression
MDedge Endocrinology
Vegetarian diets can improve high-risk cardiovascular disease
MDedge Endocrinology
Stiff arteries may cause metabolic syndrome
MDedge Endocrinology
Low-dose colchicine for ASCVD: Your questions answered
MDedge Endocrinology
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
MDedge Endocrinology
Obesity-related cardiovascular disease deaths surging
MDedge Endocrinology
Redefining CVD risk: Cardiovascular-kidney-metabolic (CKM) syndrome
MDedge Endocrinology
‘Love more’: Why doctors should promote social connection
MDedge Endocrinology